A Spotlight on Rare Maternal Health – Pediatric & Rare Liver Diseases News
In April, GLI Program Director Kristin Hatcher was invited to engage with patient advocacy groups, industry partners, and patients during the PBC Foundation’s International Summit in Edinburgh, Scotland.
How does sleep affect fatty liver disease? – NASH News
At the Academy of Managed Care Pharmacy meeting on April 16, experts discussed the emerging landscape of NASH treatments, focusing on the recent approval of Madrigal’s Rezdiffra.
Global Liver Institute Thanks Senator Bill Cassidy for His Leadership in Fatty Liver Disease Research
GLI applauds the announcement of a federally-funded study by the Agency for Healthcare Research and Quality (AHRQ) to assess the prevalence of fatty liver disease (known as metabolic-associated fatty liver disease or nonalcoholic fatty liver disease) as well as its associated costs and barriers in the US.
Early-onset cancer rates rates are increasing globally – Liver Cancer News
We extend our deepest gratitude to Dr. Jennifer Guy, Dr. Anjana Pillai, Dr. Christopher Rose, Dr. Elliot Tapper, patient advocate Bruce Dimming, and our sponsors. In case you missed it, our webinar ‘Liver Cancer Care: Management of Hepatic Encephalopathy, Ascites, and Portal Hypertension’ is available on GLI’s YouTube channel! Whether you’re a patient, caregiver, or healthcare professional, this webinar offers guidance and education to improve liver care.
Global Liver Institute Statement on the Passing of Dr. Stephen Harrison
The entire field of liver health has experienced an incredible loss. It is with great sadness that Global Liver Institute, our Liver Action Network members and the patient community express our deepest sorrow on the sudden passing of Dr Stephen Harrison. Our condolences and prayers are with Dr. Harrison’s family, friends and loved ones.